Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats

References

• Alter, M.L., et al., 2012. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clinical laboratory, 58 (7–8), 659–671.
   PubMed Web of Science ®Google Scholar
• Aluise, C.D., et al., 2011. 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-a release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free radical biology and medicine, 50 (11), 1630–1638.
   PubMed Web of Science ®Google Scholar
• Annadurai, T., Thomas, P.A., and Geraldine, P., 2013. Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin-nicotinamide-induced experimental diabetes mellitus. Free radicle research, 47 (10), 793–803.
   PubMed Web of Science ®Google Scholar
• Aydin, B., et al., 2011. The antioxidant and antigenotoxic effects of Pycnogenol(®) on rats treated with cisplatin. Biological trace element research, 142 (3), 638–650.
   PubMed Web of Science ®Google Scholar
• Bharti, S., et al., 2014. Preclinical evidence for the pharmacological actions of naringin: a review. Planta medica, 80 (6), 437–451.
   PubMed Web of Science ®Google Scholar
• Chtourou, Y., et al., 2015. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway. European journal of pharmacology, 746, 96–105.
   PubMed Web of Science ®Google Scholar
• Dabla, P.K., 2010. Renal function in diabetic nephropathy. World journal of diabetes, 1 (2), 48–56.
   PubMedGoogle Scholar
• De Beer, E.L., Bottone, A.E., and Voest, E.E., 2001. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. European journal of pharmacology, 415 (1), 1–11.
   PubMed Web of Science ®Google Scholar
• Donner, A.J., et al., 2015. CD40 Generation 2.5 antisense oligonucleotide treatment attenuates doxorubicin-induced nephropathy and kidney inflammation. Molecular therapy nucleic acids, 4, e265.
   PubMedGoogle Scholar
• Ekambaram, G., et al., 2008. Naringenin reduces tumor size and weight lost in N-methyl-N-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutrition research, 28 (2), 106–112.
   PubMed Web of Science ®Google Scholar
• Fouad, A.A., et al., 2014. Protective effect of naringenin against gentamicin-induced nephrotoxicity in rats. Environmental toxicology and pharmacology, 38 (2), 420–429.
   PubMed Web of Science ®Google Scholar
• Francis, A.R., Shetty, T.K., and Bhattacharya, R.K., 1998. Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N-nitro-N-nitrosoguanidine. Carcinogenesis, 10, 1953–1955.
   Google Scholar
• Frangogiannis, N.G., 2008. The immune system and cardiac repair. Pharmacological research, 58, 88–111.
   PubMed Web of Science ®Google Scholar
• Fridovich, I., 1997. Superoxide anion radical, superoxide dismutases, and related matters. The journal of biological chemistry, 272 (30), 18515–18517.
   PubMed Web of Science ®Google Scholar
• Ganz, P.A. and Hahn, E.E., 2008. Implementing a survivorship care plan for patients with breast cancer. Journal of clinical oncology, 26, 759–767.
   PubMed Web of Science ®Google Scholar
• Ghosh, J., et al., 2011. The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis. Biomaterials, 32, 4857–4866.
   PubMed Web of Science ®Google Scholar
• Goldwasser, J., et al., 2010. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPAR alpha, PPAR gamma and LXR alpha. PLoS One, 5, e12399.
   PubMed Web of Science ®Google Scholar
• Green, L.C., et al., 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical biochemistry, 126, 131–138.
   PubMed Web of Science ®Google Scholar
• Greenwald, R., 1985. CRC handbook for oxygen radical research. Boca Raton: CRC Press.
   Google Scholar
• Horn, H.D. and Burns, F.H., 1965. In: Hans-UIrich Bergmeyer, ed. Methods of enzymatic analysis. Cambridge, MA: Academic Press, 875–879.
   Google Scholar
• Huo, W., et al., 2010. Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplantation reviews (Orlando), 24 (3), 143–146.
   PubMedGoogle Scholar
• Injac, R., et al., 2008. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress. Pharmacological reports: PR, 60 (5), 742–749.
   PubMed Web of Science ®Google Scholar
• Karuppagounder, V., et al., 2015. Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation. International immunopharmacology, 28 (1), 154–159.
   PubMed Web of Science ®Google Scholar
• Kawaii, S., et al., 1999. Quantitation of flavonoid constituents in citrus fruits. Journal of agricultural and food chemistry, 47, 3565–3571.
   PubMed Web of Science ®Google Scholar
• Khan, R., et al., 2012a. Chrysin abrogates cisplatin-induced oxidative stress, p53 expression, goblet cell disintegration and apoptotic responses in the jejunum of Wistar rats. British journal of nutrition, 108 (9), 1574–1585.
   PubMed Web of Science ®Google Scholar
• Khan, R., et al., 2012b. Chrysin protects against cisplatin-induced colon. toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53. Toxicology and applied pharmacology, 258 (3), 315–329.
   PubMed Web of Science ®Google Scholar
• Kumar, D., et al., 2001. Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxidants and Redox signalling, 3 (1), 135–145.
   PubMed Web of Science ®Google Scholar
• Lee, C.K., et al., 2008. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice. Basic & clinical pharmacology and toxicology, 103 (1), 48–54.
   PubMed Web of Science ®Google Scholar
• Liu, C.M., Ma, J.Q., and Sun, Y.Z., 2010. Quercetin protects the rat kidney against oxidative stress-mediated DNA damage and apoptosis induced by lead. Environmental toxicology pharmacology, 30 (3), 264–271.
   PubMed Web of Science ®Google Scholar
• Mahesh, R., Bhuvana, S., and Hazeena Begum, V.M., 2009. Effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in the liver and kidney of young and aged rats. Cell biochemistry and function, 27 (6), 358–363.
   PubMed Web of Science ®Google Scholar
• Mohajeri, M., and Sahebkar, A., 2018. Protective effects of curcumin against doxorubicin-induced toxicity and resistance: a review. Critical reviews in oncology hematology, 122, 30–51.
   PubMed Web of Science ®Google Scholar
• Mohan, M., et al., 2010. Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food and chemical toxicology, 48 (1), 436–440.
   PubMed Web of Science ®Google Scholar
• Octavia, Y., et al., 2012. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. Journal of molecular cell biology, 52 (6), 1213–1225.
   Google Scholar
• Ortiz, A.R.R., et al., 2008. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes obesity and metabolism, 10 (11), 1097–2004.
   PubMed Web of Science ®Google Scholar
• Oz, E. and Ilhan, M.N., 2006. Effects of melatonin in reducing the toxic effects of doxorubicin. Molecular and cellular biochemistry, 286 (1–2), 11–15.
   PubMed Web of Science ®Google Scholar
• Ozbek, E., et al., 2009. Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways. Renal failure, 31 (5), 382–392.
   PubMed Web of Science ®Google Scholar
• Patel, K., Singh, G.K., and Patel, D.A., 2018. A review on pharmacological and analytical aspects of naringenin. Chinese journal of integrative medicine, 24 (7), 551–560.
   PubMed Web of Science ®Google Scholar
• Pick, A. and Keisari, Y., 1981. Superoxide anion a d H2O production by chemically elicited peritoneal macrophages—induction by multiple non-phagocytic stimulus. Cellular immunology, 59, 301–308.
   PubMed Web of Science ®Google Scholar
• Procházková, D., Boušová, I., and Wilhelmová, N., 2011. Antioxidant and prooxidant properties of flavonoids. Fitoterapia, 82 (4), 513–523.
   PubMed Web of Science ®Google Scholar
• Rashid, S., et al., 2013. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicology mechanisms and methods, 23 (5), 337–345.
   PubMed Web of Science ®Google Scholar
• Rayidi, S., 2011. Effect of naringenin on carbohydrate metabolism in STZ-nicotinamide induced diabetic rats. Biomirror, 2, 1–9.
   Google Scholar
• Rehman, M.U., et al., 2014a. Alleviation of hepatic injury by chrysin in cisplatin administered rats: probable role of oxidative and inflammatory markers. Pharmacological reports: PR, 66 (6), 1050–1059.
   PubMed Web of Science ®Google Scholar
• Rehman, M.U., et al., 2018a. Naringenin (4,5,7-trihydroxyflavanone) suppresses the development of precancerous lesions via controlling hyperproliferation and inflammation in the colon of Wistar rats. Environmental toxicology, 33 (4), 422–435.
   PubMed Web of Science ®Google Scholar
• Rehman, M.U., et al., 2018b. Zingerone (4-(4-hydroxy-3-methylphenyl)butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy. Archives of physiology and biochemistry, 14, 1–9.
   Google Scholar
• Rehman, M.U., et al., 2012. Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid. Molecular and cellular biochemistry, 365 (1–2), 119–127.
   PubMed Web of Science ®Google Scholar
• Rehman, M.U., et al., 2013. Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: plausible role of NF-κB. Toxicology letters, 216 (2–3), 146–158.
   PubMed Web of Science ®Google Scholar
• Rehman, M.U., et al., 2014b. D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats. Experimental biology and medicine (Maywood), 39 (4), 465–476.
   Google Scholar
• Renugadevi, J. and Prabu, S.M., 2010. Cadmium-induced hepatotoxicity in rats and the protective effect of Naringenin. Experimental and toxicological pathology, 62 (2), 171–181.
   PubMed Web of Science ®Google Scholar
• Roy, S., et al., 2016. Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events. Pharmaceutical biology, 54 (9), 1616–1627.
   PubMed Web of Science ®Google Scholar
• Saad, S.Y., Najjar, T.A., and Al-Rikabi, A.C., 2001. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacological research, 43 (3), 211–218.
   PubMed Web of Science ®Google Scholar
• Salim, S.A.R., 2012. Effect of oleo-gum-resin on ethanol-induced hepatotoxicity in rats. Journal of medical sciences, 12, 1–9.
   Google Scholar
• Santos, K.F., et al., 1999. Hypolipidemic effects of naringenin, rutin, nicotinic acid and their associations. Pharmacological research, 40 (6), 493–496.
   PubMed Web of Science ®Google Scholar
• Sayed-Ahmed, M.M., et al., 2001. Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy. Pharmacology & toxicology, 89 (3), 140–144.
   PubMedGoogle Scholar
• Schijlen, E.G., et al., 2004. Modification of flavonoid biosynthesis in crop plants. Phytochemistry, 65 (19), 2631–2648.
   PubMed Web of Science ®Google Scholar
• Shao, X., et al., 2014. Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis. PLoS one, 9 (1), e84131.
   PubMed Web of Science ®Google Scholar
• Singal, P.K., et al., 2000. Adriamycininduced heart failure: mechanism and modulation. Molecular and cellular biochemistry, 207 (1–2), 77–86.
   PubMed Web of Science ®Google Scholar
• Skovso, S., 2014. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. Journal of diabetes investigations, 5 (4), 349–358.
   PubMed Web of Science ®Google Scholar
• Smith, L.A., et al., 2010. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC cancer, 10, 337.
   PubMed Web of Science ®Google Scholar
• Surampalli, G., Nanjwade, B.K., and Patil, P.A., 2016. Safety evaluation of naringenin upon experimental exposure on rat gastrointestinal epithelium for novel optimal drug delivery. Drug delivery, 23 (2), 512–524.
   PubMed Web of Science ®Google Scholar
• Tu, H.K., et al., 2010. Manganese superoxide dismutase polymorphism and risk of gastric lesions, and its effects on chemoprevention in a Chinese population. Cancer epidemiology biomarkers and prevention, 19 (4), 1089–1097.
   PubMed Web of Science ®Google Scholar
• Vaidya, V.S., et al., 2006. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. American journal of physiology and renal physiology, 290, 517–529.
   PubMed Web of Science ®Google Scholar
• Wright, J.R., Colby, H.D., and Miles, P.R., 1981. Cytosolic factors which affect nmicrosomal lipid peroxidation in lung and liver. Archives of biochemistry and biophysics, 206, (2), 296–304.
   PubMed Web of Science ®Google Scholar